Nutex Health Stock Forecast
NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NUTX analyst consensus
Consensus (6 analysts)
strong_buy
Avg. price target
$313.67+92.86%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Nutex Health (2026-11-16), 6 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $313.67, with a high estimate of $357.00 and a low estimate of $250.00. The average target implies upside of 92.9% from the current price of $162.64.
The spread between the highest and lowest targets is 42.8%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NUTX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 17% |
| Buy | 5 | 83% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-16.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $250.00 | +53.71% |
| Average target | $313.67 | +92.86% |
| High target | $357.00 | +119.50% |